Innovotech Inc
XTSX:IOT

Watchlist Manager
Innovotech Inc Logo
Innovotech Inc
XTSX:IOT
Watchlist
Price: 0.165 CAD -2.94%
Market Cap: 6.7m CAD
Have any thoughts about
Innovotech Inc?
Write Note

Innovotech Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Innovotech Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Innovotech Inc
XTSX:IOT
Income from Continuing Operations
-CA$364.5k
CAGR 3-Years
N/A
CAGR 5-Years
-116%
CAGR 10-Years
7%
Abcellera Biologics Inc
NASDAQ:ABCL
Income from Continuing Operations
-$146.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Income from Continuing Operations
-CA$6.1m
CAGR 3-Years
9%
CAGR 5-Years
-25%
CAGR 10-Years
-35%
Replicel Life Sciences Inc
XTSX:RP
Income from Continuing Operations
-CA$69.3k
CAGR 3-Years
69%
CAGR 5-Years
51%
CAGR 10-Years
N/A
No Stocks Found

Innovotech Inc
Glance View

Market Cap
6.4m CAD
Industry
Life Sciences Tools & Services

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States and internationally. The company is headquartered in Edmonton, Alberta. The company went IPO on 2003-05-28. The firm's contract research services cover various applications, including implanted devices antimicrobial testing; antibiotic and biocide efficacy screening; agricultural diseases, food safety; dental biofilms; waterline and pipeline fouling; regulatory submission packages; consulting services; and third-party validations. The firm's assays and services include biofilm antimicrobial testing, planktonic antimicrobial testing, aerobic and anaerobic microorganisms as well as bacterial spores. Its products include InnovoSIL Antimicrobial Products, The MBEC Assay, and Agress and AgreGuard. InnovoSIL is a family of antimicrobial agents suited to coating onto or incorporation into medical devices. The MBEC assay is biofilm growth device. Agress and AgreGuard is a seed treatment and plant spray.

IOT Intrinsic Value
0.068 CAD
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Innovotech Inc's Income from Continuing Operations?
Income from Continuing Operations
-364.5k CAD

Based on the financial report for Jun 30, 2024, Innovotech Inc's Income from Continuing Operations amounts to -364.5k CAD.

What is Innovotech Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
7%

Over the last year, the Income from Continuing Operations growth was -603%.

Back to Top